Molecular model of prion transmission to humans

Emerging Infectious Diseases

Volumn 15, Issue 12, 2009, Pages 2013-2016

  Jones, Michael ^a   Wight, Darren ^a   Barron, Rona ^a   Jeffrey, Martin ^b   Manson, Jean ^a   Prowse, Christopher ^c   Ironside, James W ^a   Head, Mark W ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b VETERINARY LABORATORIES AGENCY   (United Kingdom)

^c SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN;

ARTICLE; DISEASE TRANSMISSION; GENE AMPLIFICATION; HOST SUSCEPTIBILITY; MOLECULAR INTERACTION; PRION DISEASE; PROTEIN FOLDING; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; BLOTTING, WESTERN; DISEASE SUSCEPTIBILITY; HUMANS; MICE; PRION DISEASES; PRIONS; PROTEIN FOLDING; PROTEIN ISOFORMS;

EID: 73949119010     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1512.090194     Document Type: Article

References (15)

1. Bruce ME. TSE strain variation. Br Med Bull. 2003;66:99-108. DOI: 10.1093/bmb/66.1.99
2. Prusiner SB. Prions. Proc Natl Acad Sci U S A. 1998;95:13363-83. DOI: 10.1073/pnas.95.23.13363
3. Collinge J, Clark AR. A general model of prion strains and their pathogenicity. Science. 2007;318:930-6. DOI: 10.1126/science. 1138718
4. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, et al. Lancet. 1996;347:921-5. DOI: 10.1016/S0140-6736 (96)91412-9
5. Collinge J, Sidle KC, Meads J, Ironside J, Hill AF. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature. 1996;383:685-90. DOI: 10.1038/383685a0
6. Head MW, Bunn TJ, Bishop MT, McLoughlin V, Lowrie S, McKimmie J, et al. Prion protein heterogeneity in sporadic but not variant Creutzfeldt-Jakob disease: UK cases 1991-2002. Ann Neurol. 2004;55:851-9. DOI: 10.1002/ana.20127
7. Eloit M, Adjou K, Coulpier M, Fontaine JJ, Hamel R, Lilin T, et al. BSE agent signatures in a goat. Vet Rec. 2005;156:523-4.
8. Supattapone S. Prion protein conversion in vitro. J Mol Med. 2004;82:348-56. DOI: 10.1007/s00109-004-0534-3
9. Saborio GP, Permanne B, Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature. 2001;411:810-3. DOI: 10.1038/35081095
10. Jones M, Peden AH, Prowse CV, Groner A, Manson JC, Turner ML, et al. In vitro amplification and detection of variant Creutzfeldt-Jakob disease PrPSc. J Pathol. 2007;213:21-6. DOI: 10.1002/path.2204
11. Yull HM, Ritchie DL, Langeveld JP, van Zijderveld FG, Bruce ME, Ironside JW, et al. Detection of type 1 prion protein in variant Creutzfeldt-Jakob disease. Am J Pathol. 2006;168:151-7. DOI: 10.2353/ajpath.2006.050766
12. Jeffrey M, Martin S, Thomson JR, Dingwall WS, Begara-McGorum I, Gonzalez L. Onset and distribution of tissue prp accumulation in scrapie-affected Suffolk sheep as demonstrated by sequential necropsies and tonsillar biopsies. J Comp Pathol. 2001;125:48-57.
13. Gonzalez L, Chianini F, Martin S, Siso S, Gibbard L, Reid HW, et al. Comparative titration of experiment ovine BSE infectivity in sheep and mice. J Gen Virol. 2007;88:714-7. DOI: 10.1099/vir.0.82426-0
14. Bishop MT, Hart P, Aitchison L, Baybutt HN, Plinston C, Thomson V, et al. Predicting susceptibility and incubation time of human-tohuman transmission of vCJD. Lancet Neurol. 2006;5:393-8. DOI: 10.1016/S1474-4422(06)70413-6
15. Manson JC, Cancellotti E, Hart P, Bishop MT, Barron RM. The transmissible spongiform encephalopathies: emerging and declining epidemics. Biochem Soc Trans. 2006;34:1155-8. DOI: 10.1042/BST0341155